Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/20/04 20:21 | 9/16/04 | MII | Health | BioPrd | Biological Products, (No Diag | Steel John F IV | CA | DOT | CEO | S.d | -397 | 1.20 | 0 | -331 | -4 | 8,983 | D | ||||||||||||||
4/26/04 12:28 | 4/21/04 | MIIS | Health | BioPrd | Biological Products, (No Diag | Hartounian Hartoun | CA | DO | P | S.dm | -187 | 2.67 | 0 | -70 | -66 | 37 | D | ||||||||||||||
4/26/04 12:24 | 4/21/04 | MIIS | Health | BioPrd | Biological Products, (No Diag | Kachioff William G | CA | O | CFO | S.dm | -80 | 2.67 | 0 | -30 | -100 | 0 | D | ||||||||||||||
4/20/04 18:02 | 4/16/04 | MIIS | Health | BioPrd | Biological Products, (No Diag | Kachioff William G | CA | O | CFO | S.dm | -176 | 2.73 | 0 | -64 | -100 | 0 | D | ||||||||||||||
4/20/04 18:01 | 4/16/04 | MIIS | Health | BioPrd | Biological Products, (No Diag | Hartounian Hartoun | CA | DO | P | S.dm | -349 | 2.70 | 0 | -129 | -100 | 0 | D | ||||||||||||||
4/16/04 18:26 | 4/14/04 | MIIS | Health | BioPrd | Biological Products, (No Diag | Kachioff William G | CA | O | CFO | S.dm | -71 | 2.79 | 0 | -26 | -100 | 0 | D | ||||||||||||||
4/16/04 17:49 | 4/14/04 | MIIS | Health | BioPrd | Biological Products, (No Diag | Hartounian Hartoun | CA | DO | P,COO | S.dm | -141 | 2.79 | 0 | -51 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |